Stock CSBR CHAMPIONS ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Champions Oncology, Inc.

Equities

CSBR

US15870P3073

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
5.02 USD -0.79% Intraday chart for Champions Oncology, Inc. -0.79% -10.67%
Mar. 15 Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. CI
Mar. 13 Craig-Hallum Downgrades Champions Oncology to Hold From Buy MT

Evolution of the average Target Price on Champions Oncology, Inc.

Price target over the last 5 years

History of analyst recommendation changes

67a2b5.JULVY3bLJdL4Q-h5119wrlvhsAejh30y9DU8H-Ua1h4.USS6ThStEOqAFocIuBs9yRWU72Pp8TxflUEJSKRKrm5KCrA8FJtNnbc6qQ~ca491da6423cc7e6dabba920679e601c

Analyst Recommendations on Champions Oncology, Inc.

Craig-Hallum Downgrades Champions Oncology to Hold From Buy MT
Craig Hallum Trims Champions Oncology Price target to $9 From $10, Maintains Buy Rating MT
Roth MKM Adjusts Price Target on Champions Oncology to $7.50 From $9, Maintains Buy Rating MT
Benchmark Company Downgrades Champions Oncology to Hold From Speculative Buy MT
Craig Hallum Adjusts Champions Oncology Price Target to $10 From $12, Maintains Buy Rating MT
CHAMPIONS ONCOLOGY : Roth Capital Adjusts Price Target on Champions Oncology to $16 From $13.50, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
5.02 USD
Average target price
6 USD
Spread / Average Target
+19.52%
High Price Target
6 USD
Spread / Highest target
+19.52%
Low Price Target
6 USD
Spread / Lowest Target
+19.52%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Champions Oncology, Inc.

Craig-Hallum
Roth MKM
Benchmark Company
Roth Capital Partners

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CSBR Stock
  4. Consensus Champions Oncology, Inc.